Cite
HARVARD Citation
Pohl, O. et al. (2018). Pharmacokinetics, safety and tolerability of OBE022, a selective prostaglandin F2α receptor antagonist tocolytic: A first‐in‐human trial in healthy postmenopausal women. British journal of clinical pharmacology. pp. 1839-1855. [Online].